209 related articles for article (PubMed ID: 23545288)
1. Targeting delivery of saquinavir to the brain using 83-14 monoclonal antibody-grafted solid lipid nanoparticles.
Kuo YC; Ko HF
Biomaterials; 2013 Jul; 34(20):4818-30. PubMed ID: 23545288
[TBL] [Abstract][Full Text] [Related]
2. Solid lipid nanoparticles carrying chemotherapeutic drug across the blood-brain barrier through insulin receptor-mediated pathway.
Kuo YC; Shih-Huang CY
J Drug Target; 2013 Sep; 21(8):730-8. PubMed ID: 23815407
[TBL] [Abstract][Full Text] [Related]
3. Cationic solid lipid nanoparticles with cholesterol-mediated surface layer for transporting saquinavir to the brain.
Kuo YC; Wang CC
Biotechnol Prog; 2014; 30(1):198-206. PubMed ID: 24167123
[TBL] [Abstract][Full Text] [Related]
4. Effect of electromagnetic field on endocytosis of cationic solid lipid nanoparticles by human brain-microvascular endothelial cells.
Kuo YC; Chen HH
J Drug Target; 2010 Jul; 18(6):447-56. PubMed ID: 20528098
[TBL] [Abstract][Full Text] [Related]
5. Cationic solid lipid nanoparticles with primary and quaternary amines for release of saquinavir and biocompatibility with endothelia.
Kuo YC; Wang CC
Colloids Surf B Biointerfaces; 2013 Jan; 101():101-5. PubMed ID: 22796778
[TBL] [Abstract][Full Text] [Related]
6. Transport of saquinavir across human brain-microvascular endothelial cells by poly(lactide-co-glycolide) nanoparticles with surface poly-(γ-glutamic acid).
Kuo YC; Yu HW
Int J Pharm; 2011 Sep; 416(1):365-75. PubMed ID: 21736932
[TBL] [Abstract][Full Text] [Related]
7. Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles.
Kuo YC; Su FL
Int J Pharm; 2007 Aug; 340(1-2):143-52. PubMed ID: 17418986
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor.
Kuo YC; Liang CT
Biomaterials; 2011 Apr; 32(12):3340-50. PubMed ID: 21296415
[TBL] [Abstract][Full Text] [Related]
9. Methylmethacrylate-sulfopropylmethacrylate nanoparticles with surface RMP-7 for targeting delivery of antiretroviral drugs across the blood-brain barrier.
Kuo YC; Lee CL
Colloids Surf B Biointerfaces; 2012 Feb; 90():75-82. PubMed ID: 22024400
[TBL] [Abstract][Full Text] [Related]
10. Expression of ornithine decarboxylase during the transport of saquinavir across the blood-brain barrier using composite polymeric nanocarriers under an electromagnetic field.
Kuo YC; Yu HW
Colloids Surf B Biointerfaces; 2011 Dec; 88(2):627-34. PubMed ID: 21855303
[TBL] [Abstract][Full Text] [Related]
11. Delivering etoposide to the brain using catanionic solid lipid nanoparticles with surface 5-HT-moduline.
Kuo YC; Hong TY
Int J Pharm; 2014 Apr; 465(1-2):132-42. PubMed ID: 24524828
[TBL] [Abstract][Full Text] [Related]
12. Dual targeting of solid lipid nanoparticles grafted with 83-14 MAb and anti-EGF receptor for malignant brain tumor therapy.
Kuo YC; Lee CH
Life Sci; 2016 Feb; 146():222-31. PubMed ID: 26784850
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier.
Beloqui A; Solinís MÁ; Gascón AR; del Pozo-Rodríguez A; des Rieux A; Préat V
J Control Release; 2013 Mar; 166(2):115-23. PubMed ID: 23266764
[TBL] [Abstract][Full Text] [Related]
14. Electromagnetic interference in the permeability of saquinavir across the blood-brain barrier using nanoparticulate carriers.
Kuo YC; Kuo CY
Int J Pharm; 2008 Mar; 351(1-2):271-81. PubMed ID: 17976933
[TBL] [Abstract][Full Text] [Related]
15. Solid lipid nanoparticles comprising internal Compritol 888 ATO, tripalmitin and cacao butter for encapsulating and releasing stavudine, delavirdine and saquinavir.
Kuo YC; Chung CY
Colloids Surf B Biointerfaces; 2011 Dec; 88(2):682-90. PubMed ID: 21865017
[TBL] [Abstract][Full Text] [Related]
16. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.
Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X
Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043
[TBL] [Abstract][Full Text] [Related]
17. Enhanced delivery of etoposide across the blood-brain barrier to restrain brain tumor growth using melanotransferrin antibody- and tamoxifen-conjugated solid lipid nanoparticles.
Kuo YC; Wang IH
J Drug Target; 2016 Aug; 24(7):645-54. PubMed ID: 26768307
[TBL] [Abstract][Full Text] [Related]
18. Regulation of endocytosis into human brain-microvascular endothelial cells by inhibition of efflux proteins.
Kuo YC; Lu CH
Colloids Surf B Biointerfaces; 2011 Oct; 87(1):139-45. PubMed ID: 21636258
[TBL] [Abstract][Full Text] [Related]
19. Brain targeted delivery of carmustine using solid lipid nanoparticles modified with tamoxifen and lactoferrin for antitumor proliferation.
Kuo YC; Cheng SJ
Int J Pharm; 2016 Feb; 499(1-2):10-19. PubMed ID: 26721730
[TBL] [Abstract][Full Text] [Related]
20. β-Hydroxybutyric acid grafted solid lipid nanoparticles: a novel strategy to improve drug delivery to brain.
Venishetty VK; Samala R; Komuravelli R; Kuncha M; Sistla R; Diwan PV
Nanomedicine; 2013 Apr; 9(3):388-97. PubMed ID: 22960191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
